| Name | Title | Contact Details |
|---|---|---|
Bill Laukaitis |
Chief Information Officer | Profile |
Built by science, driven by compassion. Aspenti Health is an innovative, comprehensive clinical drug testing lab that is seeking to redefine the role of the traditional healthcare testing partners. Led by experienced healthcare professionals, we are focused on shaping a future in which we are instrumental in helping our patients meet their recovery goals. We also are investing in our social mission to create lasting and effective impact through community involvement. We believe in improving patient outcomes through enhanced treatment access and patient advocacy. Unlike other testing partners, Aspenti works hand in hand with our care providers in order to better serve our mutual patient through patient-focused services such as mobile testing, data driven digital health integration, thought leadership, and strategic partnerships with leading healthcare and research institutions. It is our vision to enrich every life through diagnostic science and compassionate care.
Rippl is a new kind of mental health company focused on seniors and obsessed with its clinicians. Seniors with mental health challenges, especially neurocognitive conditions like Alzheimer`s disease and other dementias, are overlooked and under cared for, often without access to high quality, real-time, practical care.
Thornhill Research Inc. is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.
Convenience Kits Intl. is a Lynbrook, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.